Advit Jewels IPO

Incorporated in 2019, Advit Jewels is a Jaipur-based jewellery company, specializing in handcrafted fine jewellery, with expertise in Kundan, Polki, Diamond and Studded pieces under the brand name "Rambhajo". It blend traditional techniques with modern designs to create unique pieces that are both timeless and contemporary. Its product portfolio includes necklaces, earrings, rings, bangles and customized jewellery, crafted in 14K and 18K gold with diamonds and coloured stones. The company primarily works on a B2B model, supplying dealers, showrooms and retailers, but also serve B2C customers for exclusive, made-to-order jewellery. Its jewellery is 100% handmade by skilled artisans trained over generations, ensuring every piece is a masterpiece. In FY 2025, it derived 81.63% of revenue from B2B segment and 18.37% is derived from B2C segment. Manufacturing facility: It has a manufacturing unit in Jaipur (6,450 sq. ft.) is equipped with modern machines like 3D printers and casting units, allowing to handle the complete process in-house – from gold melting to polishing and quality checks. This ensures efficiency, security, and strict quality control. Customized or high-value orders are typically completed within 25–30 days. The company maintains strong quality standards with a dedicated QC team that checks every detail including design, purity, finish, and dimensions before dispatch. It has a PAN India presence with revenue generated from various states including Maharashtra, Haryana, Gujarat, Delhi, Punjab, Rajasthan, West Bengal, Uttar Pradesh, and Telangana. As of April 30, 2026, the company has a total employee base of 111 persons. Competitive Strengths Organized manufacturing under one roof Diversified product offering across customer segments Robust operational systems and risk mitigation framework Experienced leadership with proven execution capability Unwavering Commitment to Quality

Information on this page is for general awareness only and is not investment advice. Grey market premium (when shown) is unofficial and indicative. Always read the RHP/DRHP and consult a qualified adviser before investing.